Ramon Alemany Selected Research

Ramon Alemany Research Topics

Disease

56	Neoplasms (Cancer) 03/2022 - 03/2002
10	Glioma (Gliomas) 10/2009 - 10/2002
9	Infections 06/2021 - 03/2002
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 06/2009
5	Melanoma (Melanoma, Malignant) 03/2022 - 08/2002
4	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2009
4	Retinoblastoma (Glioblastoma, Retinal) 01/2019 - 05/2003
3	Adenocarcinoma 01/2022 - 01/2019
3	Brain Neoplasms (Brain Tumor) 01/2015 - 03/2004
2	Inflammation (Inflammations) 03/2022 - 07/2003
2	Thrombocytopenia (Thrombopenia) 01/2022 - 09/2012
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 10/2002
2	Bites and Stings (Sting) 01/2018 - 01/2017
1	Enterocolitis 01/2022
1	Febrile Neutropenia 01/2022
1	Virus Diseases (Viral Diseases) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 10/2018
1	Mesothelioma 10/2018
1	Leukemia 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Coinfection 09/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2015
1	Communicable Diseases (Infectious Diseases) 04/2014
1	Wounds and Injuries (Trauma) 11/2013
1	Carcinoma (Carcinomatosis) 09/2012
1	Fatigue 06/2010
1	Hyponatremia 06/2010
1	Fever (Fevers) 06/2010
1	Chills 06/2010
1	Colonic Neoplasms (Colon Cancer) 07/2009

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2003
8	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2022 - 07/2010
7	IntegrinsIBA 03/2015 - 03/2002
5	AntigensIBA 10/2018 - 01/2004
4	CytokinesIBA 03/2022 - 09/2012
4	Peptides (Polypeptides)IBA 01/2021 - 09/2007
3	Gemcitabine FDA Link 01/2022 - 04/2017
3	AntibodiesIBA 11/2021 - 01/2017
3	Antineoplastic Agents (Antineoplastics)IBA 11/2021 - 04/2004
3	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 07/2010
3	Thymidine KinaseIBA 01/2013 - 07/2009
2	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2021
2	ChemokinesIBA 03/2022 - 10/2017
2	InterferonsIBA 03/2022 - 10/2018
2	Biological ProductsIBA 01/2022 - 05/2014
2	130-nm albumin-bound paclitaxelIBA 01/2022 - 04/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 09/2012
2	Pharmaceutical PreparationsIBA 11/2021 - 01/2014
2	LigandsIBA 01/2021 - 10/2009
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 01/2014
2	Collagen Type I (Type I Collagen)IBA 01/2019 - 10/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019 - 10/2018
2	Chimeric Antigen ReceptorsIBA 01/2018 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2017 - 01/2012
2	Therapeutic UsesIBA 02/2014 - 10/2002
2	Ganciclovir (Cytovene)FDA LinkGeneric 01/2013 - 01/2011
2	Verapamil (Calan)FDA LinkGeneric 01/2012 - 05/2010
2	arginyl-glycyl-aspartic acidIBA 10/2009 - 10/2002
2	adenovirus receptorIBA 12/2008 - 05/2003
2	Retinoblastoma ProteinIBA 09/2007 - 05/2003
2	adenovirus associated RNA (VA RNA)IBA 09/2006 - 09/2003
2	Messenger RNA (mRNA)IBA 09/2006 - 07/2003
2	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 10/2002 - 03/2002
1	Interleukin-27 (Interleukin 27)IBA 03/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022
1	Codon (Codons)IBA 06/2021
1	Viral AntigensIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Toll-Like Receptor 9IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	B7-H1 AntigenIBA 10/2018
1	EnzymesIBA 10/2018
1	MesothelinIBA 10/2018
1	Arginine (L-Arginine)FDA Link 03/2018
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 03/2018
1	Folate Receptor 1IBA 01/2018
1	Neutralizing AntibodiesIBA 10/2016
1	Heparitin Sulfate (Heparan Sulfate)IBA 03/2015
1	GlycosaminoglycansIBA 03/2015
1	Metalloproteases (Metalloproteinases)IBA 10/2014
1	Matrix Metalloproteinases (MMPs)IBA 10/2014
1	dl1520 (ONYX-015)IBA 10/2014
1	VaccinesIBA 04/2014
1	Alanine Transaminase (SGPT)IBA 09/2012
1	Complementary DNA (cDNA)IBA 07/2010
1	Transaminases (Aminotransferases)IBA 06/2010
1	Docetaxel (Taxotere)FDA Link 11/2009
1	Heparin (Liquaemin)FDA LinkGeneric 10/2009
1	Sulfates (Sulfates, Inorganic)IBA 10/2009
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 10/2009
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 07/2009

Therapy/Procedure

23	Therapeutics 03/2022 - 10/2002
6	Oncolytic Virotherapy 10/2021 - 09/2003
6	Immunotherapy 09/2021 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2022 - 10/2009
4	Intravenous Administration 10/2021 - 01/2013
4	Injections 01/2019 - 10/2002
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Long-Term Care 11/2013